Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gohlke

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Candesartan cilexetil: development and preclinical studiesP Gohlke, T Jürgensen, S von Kügelgen, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1995
Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reductionW Linz, P Gohlke, T Unger, et al.
Pharmacological Research|May 19, 2000
Short treatments of normotensive and hypertensive rats by angiotensin II and nitric oxide inhibitor induce an increase of noradrenaline sensitivity in isolated vena portae preparationsJ Y Datté, P Gohlke, C Pees, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 8, 2001
At receptor inhibition affects the noradrenaline sensitivity in isolated portal vein of normotensive ratJ Y Datté, P Gohlke, C Pees, et al.
Journal of Cardiovascular Pharmacology|September 1, 1994
Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykininP Gohlke, I Kuwer, S Bartenbach, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288P Gohlke, B Schölkens, R Henning, et al.
Journal of Cardiovascular Pharmacology|January 1, 1994
The renin-angiotensin system in the heart and vascular wall: new therapeutic aspectsM Falkenhahn, P Gohlke, M Paul, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalaprilO Edling, G Bao, M Feelisch, et al.
Resuscitation|December 1, 1989
Angiotensin II and atrial natriuretic peptide in the brain: effects on volume and Na+ balanceT Unger, P Gohlke, M Kotrba, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1996
Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive ratsP Gohlke, W Linz, B A Schölkens, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Candesartan cilexetil: development and preclinical studiesP Gohlke, T Jürgensen, S von Kügelgen, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1995
Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reductionW Linz, P Gohlke, T Unger, et al.
Pharmacological Research|May 19, 2000
Short treatments of normotensive and hypertensive rats by angiotensin II and nitric oxide inhibitor induce an increase of noradrenaline sensitivity in isolated vena portae preparationsJ Y Datté, P Gohlke, C Pees, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 8, 2001
At receptor inhibition affects the noradrenaline sensitivity in isolated portal vein of normotensive ratJ Y Datté, P Gohlke, C Pees, et al.
Journal of Cardiovascular Pharmacology|September 1, 1994
Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykininP Gohlke, I Kuwer, S Bartenbach, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288P Gohlke, B Schölkens, R Henning, et al.
Journal of Cardiovascular Pharmacology|January 1, 1994
The renin-angiotensin system in the heart and vascular wall: new therapeutic aspectsM Falkenhahn, P Gohlke, M Paul, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalaprilO Edling, G Bao, M Feelisch, et al.
Resuscitation|December 1, 1989
Angiotensin II and atrial natriuretic peptide in the brain: effects on volume and Na+ balanceT Unger, P Gohlke, M Kotrba, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1996
Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive ratsP Gohlke, W Linz, B A Schölkens, et al.
Pageof 7